Client News

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

Medigene AG Presents Data on an Innovative IFN-γ Biosensor Technology at SITC 2024

Formycon Extends Management Board Contract for CEO Dr. Stefan Glombitza until 2027 and Receives Admission to Trading in the Prime Standard

Medigene AG Presents Latest Data on UniTope & TraCR Technology at PEGS and SITC 2024

Medigene AG Presents Unique Approach for Use of Optimal T Cell Receptors in TCR-Guided Modalities at Cell 2024

InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update

Nyxoah Reports Third Quarter Financial and Operating Results

Formycon Applies for Admission to the Prime Standard of the Frankfurt Stock Exchange

Secarna Announces Appointment of Konstantin Petropoulos as Chief Executive Officer

InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference